Arrowhead Pharmaceuticals, Inc. (FRA:HDP1)

Arrowhead Pharmaceuticals Statistics

Total Valuation

FRA:HDP1 has a market cap or net worth of EUR 7.56 billion. The enterprise value is 7.37 billion.

Market Cap	7.56B
Enterprise Value	7.37B

Important Dates

The last earnings date was Thursday, February 5, 2026.

Earnings Date	Feb 5, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	140.03M
Shares Outstanding	n/a
Shares Change (YoY)	+10.94%
Shares Change (QoQ)	+2.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	122.03M

Valuation Ratios

The trailing PE ratio is 43.87.

PE Ratio	43.87
Forward PE	n/a
PS Ratio	8.13
PB Ratio	15.77
P/TBV Ratio	15.79
P/FCF Ratio	27.56
P/OCF Ratio	26.15
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.38, with an EV/FCF ratio of 26.87.

EV / Earnings	42.78
EV / Sales	7.96
EV / EBITDA	25.38
EV / EBIT	28.89
EV / FCF	26.87

Financial Position

The company has a current ratio of 3.38, with a Debt / Equity ratio of 1.24.

Current Ratio	3.38
Quick Ratio	3.26
Debt / Equity	1.24
Debt / EBITDA	2.04
Debt / FCF	2.17
Interest Coverage	3.33

Financial Efficiency

Return on equity (ROE) is 75.50% and return on invested capital (ROIC) is 81.47%.

Return on Equity (ROE)	75.50%
Return on Assets (ROA)	14.35%
Return on Invested Capital (ROIC)	81.47%
Return on Capital Employed (ROCE)	23.92%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.31M
Profits Per Employee	242,291
Employee Count	711
Asset Turnover	0.83
Inventory Turnover	n/a

Taxes

In the past 12 months, FRA:HDP1 has paid 18.18 million in taxes.

Income Tax	18.18M
Effective Tax Rate	8.37%

Stock Price Statistics

The stock price has increased by +177.45% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+177.45%
50-Day Moving Average	56.27
200-Day Moving Average	31.36
Relative Strength Index (RSI)	47.01
Average Volume (20 Days)	50

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.50

Income Statement

In the last 12 months, FRA:HDP1 had revenue of EUR 929.19 million and earned 172.27 million in profits. Earnings per share was 1.26.

Revenue	929.19M
Gross Profit	929.19M
Operating Income	255.99M
Pretax Income	217.11M
Net Income	172.27M
EBITDA	277.36M
EBIT	255.99M
Earnings Per Share (EPS)	1.26

Balance Sheet

The company has 779.06 million in cash and 594.63 million in debt, with a net cash position of 184.43 million.

Cash & Cash Equivalents	779.06M
Total Debt	594.63M
Net Cash	184.43M
Net Cash Per Share	n/a
Equity (Book Value)	479.25M
Book Value Per Share	3.52
Working Capital	704.33M

Cash Flow

In the last 12 months, operating cash flow was 288.99 million and capital expenditures -14.73 million, giving a free cash flow of 274.25 million.

Operating Cash Flow	288.99M
Capital Expenditures	-14.73M
Free Cash Flow	274.25M
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of 27.55% and 18.54%.

Gross Margin	100.00%
Operating Margin	27.55%
Pretax Margin	23.37%
Profit Margin	18.54%
EBITDA Margin	29.85%
EBIT Margin	27.55%
FCF Margin	29.52%

Dividends & Yields

FRA:HDP1 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.94%
Shareholder Yield	-10.94%
Earnings Yield	2.28%
FCF Yield	3.63%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 17, 2011. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 17, 2011
Split Type	Reverse
Split Ratio	0.1

Scores

FRA:HDP1 has an Altman Z-Score of 2.55 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.55
Piotroski F-Score	6